Literature DB >> 33468099

Neurocritical care complications and interventions influence the outcome in aneurysmal subarachnoid hemorrhage.

Alexander Hammer1, Frank Erbguth2, Matthias Hohenhaus3, Christian M Hammer4, Hannes Lücking5, Markus Gesslein6, Monika Killer-Oberpfalzer7, Hans-Herbert Steiner8, Hendrik Janssen9.   

Abstract

BACKGROUND: This observational study was performed to show the impact of complications and interventions during neurocritical care on the outcome after aneurysmal subarachnoid hemorrhage (SAH).
METHODS: We analyzed 203 cases treated for ruptured intracranial aneurysms, which were classified regarding clinical outcome after one year according to the modified Rankin Scale (mRS). We reviewed the data with reference to the occurrence of typical complications and interventions in neurocritical care units.
RESULTS: Decompressive craniectomy (odds ratio 21.77 / 6.17 ; p < 0.0001 / p = 0.013), sepsis (odds ratio 14.67 / 6.08 ; p = 0.037 / 0.033) and hydrocephalus (odds ratio 3.71 / 6.46 ; p = 0.010 / 0.00095) were significant predictors for poor outcome and death after one year beside "World Federation of Neurosurgical Societies" (WFNS) grade (odds ratio 3.86 / 4.67 ; p < 0.0001 / p < 0.0001) and age (odds ratio 1.06 / 1.10 ; p = 0.0030 / p < 0.0001) in our multivariate analysis (binary logistic regression model).
CONCLUSIONS: In summary, decompressive craniectomy, sepsis and hydrocephalus significantly influence the outcome and occurrence of death after aneurysmal SAH.

Entities:  

Keywords:  Decompressive craniectomy; Intracranial aneurysm; Neurocritical care; Outcome; Subarachnoid hemorrhage; Vascular disorders

Mesh:

Year:  2021        PMID: 33468099      PMCID: PMC7814559          DOI: 10.1186/s12883-021-02054-6

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.474


  45 in total

1.  Suboptimum hemicraniectomy as a cause of additional cerebral lesions in patients with malignant infarction of the middle cerebral artery.

Authors:  S Wagner; H Schnippering; A Aschoff; J A Koziol; S Schwab; T Steiner
Journal:  J Neurosurg       Date:  2001-05       Impact factor: 5.115

2.  Aggressive CSF diversion reverses delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a case report.

Authors:  Jennifer E Fugate; Alejandro A Rabinstein; Eelco F M Wijdicks; Giuseppe Lanzino
Journal:  Neurocrit Care       Date:  2012-08       Impact factor: 3.210

3.  Guidelines for the management of severe traumatic brain injury. IV. Infection prophylaxis.

Authors:  Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright
Journal:  J Neurotrauma       Date:  2007       Impact factor: 5.269

Review 4.  Early decompressive hemicraniectomy in older patients with nondominant hemispheric infarction does not improve outcome.

Authors:  H Bart van der Worp; L Jaap Kappelle
Journal:  Stroke       Date:  2011-02-03       Impact factor: 7.914

5.  Prognostic factors in delayed ischaemic deficit with vasospasm in patients undergoing early aneurysm surgery.

Authors:  M Shimoda; S Oda; R Tsugane; O Sato
Journal:  Br J Neurosurg       Date:  1997-06       Impact factor: 1.596

6.  Health-related quality of life after aneurysmal subarachnoid hemorrhage: impacts of bleeding severity, computerized tomography findings, surgery, vasospasm, and neurological grade.

Authors:  B O Hütter; I Kreitschmann-Andermahr; J M Gilsbach
Journal:  J Neurosurg       Date:  2001-02       Impact factor: 5.115

7.  Chronic hydrocephalus that requires shunting in aneurysmal subarachnoid haemorrhage [a-SAH]: its impact on clinical outcome.

Authors:  W S Poon; S C P Ng; G K C Wong; L Y C Wong; M T V Chan
Journal:  Acta Neurochir Suppl       Date:  2008

8.  Cigarette smoking and outcomes after aneurysmal subarachnoid hemorrhage: a nationwide analysis.

Authors:  Hormuzdiyar H Dasenbrock; Robert F Rudy; Pui Man Rosalind Lai; Timothy R Smith; Kai U Frerichs; William B Gormley; M Ali Aziz-Sultan; Rose Du
Journal:  J Neurosurg       Date:  2017-10-27       Impact factor: 5.115

9.  International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized trial.

Authors:  Andrew Molyneux; Richard Kerr; Irene Stratton; Peter Sandercock; Mike Clarke; Julia Shrimpton; Rury Holman
Journal:  J Stroke Cerebrovasc Dis       Date:  2002 Nov-Dec       Impact factor: 2.136

10.  Impact of Complications and Comorbidities on the Intensive Care Length of Stay after Aneurysmal Subarachnoid Haemorrhage.

Authors:  Alexander Hammer; Gholamreza Ranaie; Frank Erbguth; Matthias Hohenhaus; Martin Wenzl; Monika Killer-Oberpfalzer; Hans-Herbert Steiner; Hendrik Janssen
Journal:  Sci Rep       Date:  2020-04-10       Impact factor: 4.379

View more
  3 in total

1.  Acute hydrocephalus and delayed cerebral infarction after aneurysmal subarachnoid hemorrhage.

Authors:  Axel Masson; Grégoire Boulouis; Kevin Janot; Denis Herbreteau; Jean-Phlippe Cottier; Richard Bibi; Clara Cohen; Sandra Obry; Stéphane Velut; Aymeric Amelot; Héloïse Ifergan
Journal:  Acta Neurochir (Wien)       Date:  2022-08-02       Impact factor: 2.816

2.  XGBoost Machine Learning Algorithm for Prediction of Outcome in Aneurysmal Subarachnoid Hemorrhage.

Authors:  Ruoran Wang; Jing Zhang; Baoyin Shan; Min He; Jianguo Xu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-03-29       Impact factor: 2.570

3.  Standardized Classification of Cerebral Vasospasm after Subarachnoid Hemorrhage by Digital Subtraction Angiography.

Authors:  Helena Merkel; Dirk Lindner; Khaled Gaber; Svitlana Ziganshyna; Jennifer Jentzsch; Simone Mucha; Thilo Gerhards; Sabine Sari; Annika Stock; Felicitas Vothel; Lea Falter; Ulf Quäschling; Karl-Titus Hoffmann; Jürgen Meixensberger; Dirk Halama; Cindy Richter
Journal:  J Clin Med       Date:  2022-04-03       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.